Latest filing published 13 Mar 2026 for Lemaitre Vascular INC, €80k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Trent G. Kamke (chief executive) discloses dealings in Lemaitre Vascular Inc to SEC (Form 4). In total, 37 filings cover trades dated from 9 June 2021 to 11 March 2026.
On the market, this insider has only sold: 2 sales, €522k in total. The rest of the record consists of 12 share grants and 23 option exercises.
The latest filing, published on 13 March 2026, reports an option exercise of €80k in Lemaitre Vascular Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 37 declarations